Exact Sciences Corporation (EXAS): Price and Financial Metrics
Exact Sciences Corporation (EXAS)
Today's Latest Price: $88.06 USD
1.72 (-1.92%)
Updated Jan 17 12:00am
Add EXAS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 55 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
EXAS Stock Summary
- EXAS has a market capitalization of $11,644,640,062 -- more than approximately 85.73% of US stocks.
- EXAS's price/sales ratio is 16.09; that's higher than the P/S ratio of 92.72% of US stocks.
- As for revenue growth, note that EXAS's revenue has grown 81.43% over the past 12 months; that beats the revenue growth of 93.19% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Exact Sciences Corp, a group of peers worth examining would be IRTC, NVRO, YEXT, ATRC, and LNDC.
- EXAS's SEC filings can be seen here. And to visit Exact Sciences Corp's official web site, go to www.exactsciences.com.
EXAS Daily Price Range
EXAS 52-Week Price Range
EXAS Stock Price Chart More Charts
EXAS Price/Volume Stats
| Current price | $88.06 | 52-week high | $123.99 |
| Prev. close | $89.78 | 52-week low | $75.35 |
| Day low | $86.85 | Volume | 2,971,900 |
| Day high | $90.40 | Avg. volume | 2,791,833 |
| 50-day MA | $88.12 | Dividend yield | N/A |
| 200-day MA | $100.71 | Market Cap | 11.43B |
Exact Sciences Corporation (EXAS) Company Bio
Exact Sciences is a molecular diagnostics company focused on gastrointestinal cancers. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. The company was founded in 1995 and is based in Madison, Wisconsin.
Top Stories View All
3 Vital Investing Strategies
Best & Worst Performing Stock Industries for January 17, 2020
Best & Worst Performing Small Cap Stocks for January 17, 2020
Best & Worst Performing Mid Cap Stocks for January 17, 2020
Best & Worst Performing Large Cap Stocks for January 17, 2020
View All Top Stories
Loading social stream, please wait...